Evidence map›Paper›PMID 34637850›Full record

ArticleThe Journal of hospital infection2022

Development and validation of technologies suitable for the decontamination and re-use of contaminated N95 filtering facepiece respirators in response to the COVID-19 pandemic.

J Alt, R Eveland, A Fiorello, B Haas, J Meszaros, B McEvoy, C Ridenour, D Shaffer, W Yirava, L Ward

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of hospital infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

J AltSTERIS Healthcare, Mentor, OH, USA.
R EvelandSTERIS Healthcare, Mentor, OH, USA.
A FiorelloSTERIS Healthcare, Mentor, OH, USA.
B HaasSTERIS Canada ULC, Québec, QC, Canada.
J MeszarosSTERIS Healthcare, Mentor, OH, USA.
B McEvoySTERIS Applied Sterilization Technologies, Tullamore, Ireland. Electronic address: brian_j_mcevoy@steris.com.
C RidenourSTERIS Healthcare, Mentor, OH, USA.
D ShafferSTERIS Healthcare, Mentor, OH, USA.
W YiravaSTERIS Healthcare, Mentor, OH, USA.
L WardSTERIS Healthcare, Mentor, OH, USA.
Steris (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) has brought significant challenges to society globally, particularly in the area of healthcare provision. A pressing need existed in protecting those tasked with delivering healthcare solutions during the COVID-19 crisis by providing solutions for preserving adequate supplies of effective personal protective equipment (PPE).

aimTo evaluate and validate available methods for the decontamination of N95 filtering facepiece respirators (FFRs) while maintaining functionality during re-use.

methodsMultiple low-temperature steam and vaporized hydrogen peroxide (VHP) technologies were assessed for inactivation of Mycobacterium spp. and feline calicivirus (employed as representatives of the contamination challenge).

findingsVirus (≥3log

conclusionThe methods have been validated and were authorized by the US Food and Drug Administration under a temporary emergency use authorization. Based on the findings, opportunities exist for development and deployment of decontamination methods made from simple, general purpose materials and equipment should a future need arise.

Indexed as

COVID-19DecontaminationEquipment ReuseHumansN95 RespiratorsPandemicsSARS-CoV-2COVID-19DecontaminationMoist heatMycobacteriumN95 face masksVaporized hydrogen peroxide

Identifiers

PMID34637850
PMCPMC8501551
OpenAlexW3205659848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.